The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index; 28 of the 50 sources its claims cite were checked for support.
The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial
Open accessAbstract
Background: The risk of breast cancer patients for long-term side effects of therapy such as neurotoxicity and cardiotoxicity as well as late effects regarding comorbidities varies from individual to individual. Personalised follow-up care concepts that are tailored to individual needs and the risk of recurrences, side effects and late effects are lacking in routine care in Germany. Methods: We describe the methodology of BETTER-CARE, a parallel-arm cluster-randomised controlled trial conducted at 15 intervention and 15 control centres, aiming to recruit 1140 patients, and the results of the pilot phase. The needs- and risk-adapted complex intervention, based on existing development frameworks, includes a multidisciplinary network and digital platforms for symptom and need documentation and just-in-time adaptive interventions. The control group comprises usual care according to clinical guidelines. The primary outcome is health-related quality of life (EORTC QLQ-C30 global health), and secondary outcomes include treatment adherence. Results: The 2-month pilot phase comprising 16 patients in one intervention and one control pilot centre demonstrated the feasibility of the BETTER-CARE approach. Discussion: BETTER-CARE is a feasible intervention and study concept, investigating individualised needs- and risk-adapted breast cancer follow-up care in Germany. If successful, the approach could be implemented in German routine care. Trial registration: German Clinical Trial Register DRKS00028840. Registered on April 2022. © The Author(s) 2024.
Overview
CoChat Summary
TL;DR
BETTER-CARE is a cluster-randomised, needs- and risk-adapted breast cancer follow-up programme in Germany that combines a multidisciplinary network, electronic records, phone-based assessment, and digital apps. A 2-month pilot with 16 patients found the approach feasible, supporting progression to the main trial.
Key findings
- The main trial is a parallel-arm cluster-randomised controlled trial with 30 centres (15 intervention, 15 control) aiming to recruit 1140 patients; the study runs from March 2023 until June 2025.
- In the 2-month pilot phase, 16 patients were recruited (7 intervention, 9 control), and the authors report that this “demonstrated the feasibility” of the BETTER-CARE approach.
- Pilot app testing suggested acceptable usability: the PIA Health app had a median uMARS-G score of 4.3 (range 3.7–4.4); 3 participants used it at least five times, 1 used it less frequently, and 1 not at all.
- Process indicators in the pilot showed partial engagement with other components: 5 of 7 intervention patients completed the online survey on intervention components, and 1 participant was prompted to further treatment by the needs-assessment phone call.
Methods
- Design: Parallel-arm cluster-randomised controlled trial with Breast Cancer Centres as clusters; 30 centres were selected after inviting 181, with randomisation to 15 intervention and 15 control centres.
- Sample/data: Eligible participants were breast cancer patients aged 18+ at the end of curative primary treatment, excluding metastatic disease, lack of digital infrastructure, or participation in another digital follow-up programme. Pilot feasibility testing included 16 patients from one intervention and one control pilot centre.
- Main analysis: The planned primary analysis uses a linear mixed effects model for the EORTC QLQ-C30 global health status/QoL outcome at 12 months, with centre as a random effect; analyses are modified intention-to-treat, with secondary multivariable and sensitivity analyses.
Limitations
- The paper states that the pilot phase was small and had a short follow-up duration, limiting what could be tested.
- The pilot had too few intervention patients to test referral from the PIA Health app to the ACTonCancer intervention because no patient exceeded the predefined cut-off.
- The authors note that only a small number of responses were obtained from relatives and gynaecologists in private practice, limiting conclusions about those groups.
- The text also makes evident that there is a potential self-selection bias because three centres dropped out after randomisation and were replaced, and the authors explicitly say a self-selection bias cannot be ruled out.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
15 Valid · 2 Not valid · 7 Not checked · 78 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“breast cancer survivors report frequently unmet needs for long-term support [3–5].”
§ The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial > Introduction
What the sources say
- Could not verifycites [3] Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Niksic M, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023–75. sourceExperimental — accuracy not yet measured
The Results (Women’s cancers > Breast; page unavailable) report five-year survival rates, while the Discussion (page unavailable) addresses cancer-care costs and health-system performance. Searches for unmet needs and long-term supportive care found no passage about breast cancer survivors reporting such needs. (LLM, conf=0.73)
- Not checked — no full text of the sourcecites [4] Fiszer C, Dolbeault S, Sultan S, Bredart A. Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review. Psychooncology. 2014;23(4):361–74. source
- Not checked — no full text of the sourcecites [5] Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuffner R. Effects of Psycho-Oncologic Interventions on Emotional Distress and Quality of Life in Adult Patients With Cancer: Systematic Review and Meta-Analysis. J Clin Oncol. 2013;31(6):782–93. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Internet-based interventions can be an effective way to support people with cancer.”
§ The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial > Introduction
What the sources say
- Supportedcites [22] Bendig E, Bauereiss N, Ebert D, Snoek F, Andersson G, Baumeister H. Internet-based interventions in chronic somatic disease. Deutsches Arzteblatt International. 2018;115(40):659-+. source
In “Changing lifestyle factors” (p. 4), the review reports improved sleep efficiency among cancer survivors receiving cognitive-behavioral internet- and mobile-based interventions compared with controls. This supports the cautious claim that such interventions can help people affected by cancer, though the reported benefit concerns sleep. (LLM, conf=0.91)
- Supportedcites [23] Golita S, Baban A. A systematic review of the effects of internet-based psychological interventions on emotional distress and quality of life in adult cancer patients. Journal of Evidence-Based Psychotherapies. 2019;19(2):47–78. source
The Background (page not provided) describes web-based interventions as having promising potential for cancer symptom management. The claim’s “can be” reflects that cautious assessment; the review also notes that study heterogeneity prevents definite conclusions. (LLM, conf=0.86)
- Partly supportedcites [24] Sander L, Reusch L, Baumeister H. Effectiveness of internet-based interventions for the prevention of mental disorders: a systematic review and meta-analysis. JMIR Ment Health. 2016;3(3):e38. sourceExperimental — accuracy not yet measured
The Results sections on Depression and Post-Traumatic Stress Disorder describe Web-based programs for cancer survivors and patients, and the Effectiveness section finds small, significant short- and medium-term benefits for depression interventions overall. It does not establish a cancer-specific effectiveness result, so the claim's implication that these interventions are effective for people with cancer is only partly supported. (LLM, conf=0.83)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There is insufficient evidence that supporting patients’ self-management alone can effectively improve patient-reported outcomes, health care or clinical outcomes [32].”
§ The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial > Methods The BETTER-CARE study protocol was developed following the SPIRIT 2013 statement (see Additional file 1) [25]. BETTER-CARE is a parallel-arm cluster-randomised controlled trial with 30 clusters. The study is running from March 2023 until June 2025. A cluster is defined as Breast Cancer Centres, where acute care is provided for a defined source population. All German Breast Cancer Centres that were certified at enrolment by the German Cancer Society (“Deutsche Krebsgesellschaft”) and the German Society for Senology and that could export routine data via the Onkozert© software, as this was part of the study, were eligible and invited to the study by the German Cancer Society [26]. Breast Cancer Centres in Germany are assessed by the Certification Commission based on the following criteria, among others, for certification: Tumour conference with participation of defined disciplines and demonstration of imaging material, implementation of designated clinical guidelines and assurance of availability, number of primary breast cancer cases per year with initial certification ≥ 100 primary cases, 24-h accessibility of the main clinical cooperation partners, cooperation with psycho-oncology, social services, self-help, genetic counselling, gene analyses, physiotherapy, laboratory, palliative medicine [27]. In 2020, 284 sites were certified and a total of 61,356 primary breast cancer cases were treated [28]. Of the Breast Cancer Centres that expressed interest, a predetermined number of 30 Breast Cancer Centres were selected whose catchment areas did not overlap to avoid contamination bias. Furthermore, no other follow-up programme with digital applications should be offered regularly at the Breast Cancer Centre. Both university and non-university clinics were included. The size of the city and the centre were recorded, as these are potential confounding variables regarding the quality of care. Since the Breast Cancer Centres of the intervention group provide consulting and education, no blinding of patients and physicians is possible. In the control condition, patients receive usual care according to German guidelines and a study-specific assessment of primary and secondary outcomes. The study was registered on the German Clinical Trials Register (DRKS00028840) in April 2022. > Intervention programme
What the sources say
- Partly supportedcites [32] Cuthbert C, Farragher J, Hemmelgarn B, Ding Q, McKinnon G, Cheung W. Self-management interventions for cancer survivors: A systematic review and evaluation of intervention content and theories. Psychooncology. 2019;28(11):2119–40. sourceExperimental — accuracy not yet measured
Section 4.1 (Clinical implications; page not available) says findings on the effects of self-management interventions are inconclusive for cancer survivors. Section 3.4 reports mixed patient-reported results and very limited measurement of health care and clinical outcomes. The review does not establish the claim for patients generally or specifically assess self-management support ‘alone.’ (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The development of the intervention was guided by the recommendations of the Medical Research Council (MRC) framework for complex interventions [29–31].”
§ The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial > Methods The BETTER-CARE study protocol was developed following the SPIRIT 2013 statement (see Additional file 1) [25]. BETTER-CARE is a parallel-arm cluster-randomised controlled trial with 30 clusters. The study is running from March 2023 until June 2025. A cluster is defined as Breast Cancer Centres, where acute care is provided for a defined source population. All German Breast Cancer Centres that were certified at enrolment by the German Cancer Society (“Deutsche Krebsgesellschaft”) and the German Society for Senology and that could export routine data via the Onkozert© software, as this was part of the study, were eligible and invited to the study by the German Cancer Society [26]. Breast Cancer Centres in Germany are assessed by the Certification Commission based on the following criteria, among others, for certification: Tumour conference with participation of defined disciplines and demonstration of imaging material, implementation of designated clinical guidelines and assurance of availability, number of primary breast cancer cases per year with initial certification ≥ 100 primary cases, 24-h accessibility of the main clinical cooperation partners, cooperation with psycho-oncology, social services, self-help, genetic counselling, gene analyses, physiotherapy, laboratory, palliative medicine [27]. In 2020, 284 sites were certified and a total of 61,356 primary breast cancer cases were treated [28]. Of the Breast Cancer Centres that expressed interest, a predetermined number of 30 Breast Cancer Centres were selected whose catchment areas did not overlap to avoid contamination bias. Furthermore, no other follow-up programme with digital applications should be offered regularly at the Breast Cancer Centre. Both university and non-university clinics were included. The size of the city and the centre were recorded, as these are potential confounding variables regarding the quality of care. Since the Breast Cancer Centres of the intervention group provide consulting and education, no blinding of patients and physicians is possible. In the control condition, patients receive usual care according to German guidelines and a study-specific assessment of primary and secondary outcomes. The study was registered on the German Clinical Trials Register (DRKS00028840) in April 2022. > Intervention programme
What the sources say
- Not matchedcites [29] Medical Research Council. A framework for the development and evaluation of RCTs for complex interventions to improve health. London: MRC; 2000.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Supportedcites [30] Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. British Medical Journal. 2008;337:7676. source
The Abstract identifies the paper as a summary of the MRC’s revised guidance for complex interventions. The “Developing a complex intervention” section gives recommendations for development, including identifying existing evidence and developing theory. The citation supports the framework being invoked; whether the citing authors followed it is their own account. (LLM, conf=0.92)
- Supportedcites [31] Skivington K, Matthews L, Simpson S, Craig P, Baird J, Blazeby J, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. Bmj-British Medical Journal. 2021;374:374. source
The paper introduces the MRC’s updated framework for developing and evaluating complex interventions (Abstract; Development of the Framework section, page unavailable). Its “Phases and core elements of complex intervention research” section explicitly includes intervention development and sets out elements to consider during that phase. This supports citing the paper as guidance for intervention development; whether the citing authors followed it is their own account. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The basis for screening and intervention is the National Comprehensive Cancer Network guideline on fatigue [38–42].”
§ The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial > Methods The BETTER-CARE study protocol was developed following the SPIRIT 2013 statement (see Additional file 1) [25]. BETTER-CARE is a parallel-arm cluster-randomised controlled trial with 30 clusters. The study is running from March 2023 until June 2025. A cluster is defined as Breast Cancer Centres, where acute care is provided for a defined source population. All German Breast Cancer Centres that were certified at enrolment by the German Cancer Society (“Deutsche Krebsgesellschaft”) and the German Society for Senology and that could export routine data via the Onkozert© software, as this was part of the study, were eligible and invited to the study by the German Cancer Society [26]. Breast Cancer Centres in Germany are assessed by the Certification Commission based on the following criteria, among others, for certification: Tumour conference with participation of defined disciplines and demonstration of imaging material, implementation of designated clinical guidelines and assurance of availability, number of primary breast cancer cases per year with initial certification ≥ 100 primary cases, 24-h accessibility of the main clinical cooperation partners, cooperation with psycho-oncology, social services, self-help, genetic counselling, gene analyses, physiotherapy, laboratory, palliative medicine [27]. In 2020, 284 sites were certified and a total of 61,356 primary breast cancer cases were treated [28]. Of the Breast Cancer Centres that expressed interest, a predetermined number of 30 Breast Cancer Centres were selected whose catchment areas did not overlap to avoid contamination bias. Furthermore, no other follow-up programme with digital applications should be offered regularly at the Breast Cancer Centre. Both university and non-university clinics were included. The size of the city and the centre were recorded, as these are potential confounding variables regarding the quality of care. Since the Breast Cancer Centres of the intervention group provide consulting and education, no blinding of patients and physicians is possible. In the control condition, patients receive usual care according to German guidelines and a study-specific assessment of primary and secondary outcomes. The study was registered on the German Clinical Trials Register (DRKS00028840) in April 2022. > Intervention programme
What the sources say
- Not matchedcites [38] Nationales Centrum für Tumorerkrankungen Heidelberg. Erschöpfung bei Krebs - Fatigue. 2 ed. 2023. https://www.nct-heidelberg.de/fileadmin/media/nct-heidelberg/flyer/KVBW_NCT_Fatigue_Patientenratgeber_2023.pdf.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Could not verifycites [39] Mustian K, Alfano C, Heckler C, Kleckner A, Kleckner I, Leach C, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue a meta-analysis. JAMA Oncol. 2017;3(7):961–8. sourceExperimental — accuracy not yet measured
The References list the NCCN guideline on cancer-related fatigue, but the paper does not say that it is the basis for screening and intervention. Its Conclusions recommend exercise and psychological interventions; a search for NCCN guidance on screening and intervention did not establish the claimed basis. (LLM, conf=0.70)
- Partly supportedcites [40] Campbell K, Winters-Stone K, Wiskemann J, May A, Schwartz A, Courneya K, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–90. sourceExperimental — accuracy not yet measured
In “Implementing FITT Prescriptions in Practice” (page unavailable), the paper says that special considerations and modifications to exercise programs were adapted from NCCN guidelines. Its “Fatigue” section discusses exercise interventions, but our copy does not say that the NCCN fatigue guideline is the basis for both screening and intervention. (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [41] Kuhnt S, Friedrich M, Schulte T, Cella D, Hinz A. Screening properties of the diagnostic criteria for cancer-related fatigue. Oncology Research and Treatment. 2019;42(9):440–5. source
- Not matchedcites [42] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: cancer-related fatigue. 2022:2022.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
10 more claims
Create a free account to see all 102 claims and to verify the 2 references still open.
- Probably not a substantial claim. 70
- It may state two separate claims as one. 38
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“Breast cancer is the most common malignant tumour in Germany and worldwide [1, 2].”
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 1×
“Study data is managed using REDCap© electronic data capture tools hosted at the University of Würzburg [46, 47].”
The REDCap consortium: building an international community of software platform partners
Harris, P. A., Taylor, R., Minor, B. L., Elliott, V., Fernandez, M., O'Neal, L., McLeod, L., Delacqua, G., Delacqua, F., Kirby, J., et al. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103208 · Cited by 24,013 · cited 1×
“Study data is managed using REDCap© electronic data capture tools hosted at the University of Würzburg [46, 47].”
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
(2013) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/103.1437-1588 · Cited by 11,796
Developing and evaluating complex interventions: the new Medical Research Council guidance
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2008) · BMJ · doi:10.1136/bmj.a1655 · Cited by 10,995
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
Chan, A.-W., Tetzlaff, J. M., Altman, D. G., Laupacis, A., Gøtzsche, P. C., Krleža-Jerić, K., Hróbjartsson, A., Mann, H., Dickersin, K., Berlin, J. A., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-3-201302050-00583 · Cited by 7,363 · cited 1×
“The BETTER-CARE study protocol was developed following the SPIRIT 2013 statement (see Additional file 1) [25].”
Process evaluation of complex interventions: Medical Research Council guidance
Moore, G. F., Audrey, S., Barker, M., Bond, L., Bonell, C., Hardeman, W., Moore, L., O'Cathain, A., Tinati, T., Wight, D., et al. (2015) · BMJ · doi:10.1136/bmj.h1258 · Cited by 6,204 · cited 1×
“During the study, a process evaluation is carried out in accordance with the principles of the MRC to examine the implementation of the study intervention [51].”
Allemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Skivington, K., Matthews, L., Simpson, S. A., Craig, P., Baird, J., Blazeby, J. M., Boyd, K. A., Craig, N., French, D. P., McIntosh, E., et al. (2021) · BMJ · doi:10.1136/bmj.n2061 · Cited by 5,808 · cited 1×
“The development of the intervention was guided by the recommendations of the Medical Research Council (MRC) framework for complex interventions [29–31].”
Research works printed but not linked: 2
- Medical Research Council. A framework for the development and evaluation of RCTs for complex interventions to improve health. London: MRC; 2000.
- Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A, et al. EORTC QLQ-C30 Scoring Manual (3rd edition). Brussels: EORTC; 2001.
Cited by
Vogel, C., Kraft, R., Lima, R. A., Idrees, A. R., Steiger, P., & Pryss, R. C. (2025) · Communications in computer and information science · doi:10.1007/978-3-031-94950-0_3 · Cited by 6
Self-citationPomey, M., Nabi, H., Côté, M., Nelea, M. I., Boubaker, A., Vialaron, C., Normandin, L., & Lesperance-Huot, C. (2026) · Canadian Journal of Public Health · doi:10.17269/s41997-025-01095-5 · Cited by 1
“…various components draw on several approaches to meet the varied needs of patients, as they cannot be fully met by a single intervention, require the collaboration of multiple players from different sectors, and adopt strategies adapted to a diverse range of patient profiles (Horn et al., 2024).”
Schäfer, A., Wendel, J., Franke, I., et al. (2026) · Trials · doi:10.1186/s13063-026-09858-2
Self-citation
Metadata
- Authors
- Schäfer, A., Wendel, J., Franke, I., Bauer, A., Baumeister, H., Bendig, E., Brucker, S. Y., Deutsch, T. M., Garatva, P., Haas, K., Heil, L., Hügen, K., Manger, H., Pryss, R., Rücker, V., Salmen, J., Szczesny, A., Vogel, C., Wallwiener, M., Wöckel, A., Heuschmann, P. U., the BETTER-CARE Study Group, Ast, A., Belke, K., Beurer, B., Bolkenius, P., Freese, K., Frumkin, N., Gnauert, K., Graf, H., Hackmann, J., Hartmann, C., Hesse, T., Hopp, M., Keil, E., Lehnert, A., Müller, C., Mundhenke, C., Niestroj, H. P., Nixdorf, A., Pankert, K., Perez, S., Radosa, J., Rezek, D., Seldte, J.-P., Stalzer, G., Sykorova, Z., Tenger, M., Volmer, L., Würfel, K., & Zorr, A.
- Affiliations
- University of Würzburg (DE)
- Universitätsklinikum Würzburg (DE)
- Universität Ulm (DE)
- Universitäts Frauenklinik (DE)
- University Hospital Heidelberg (DE)
- University Hospital in Halle (DE)
- ORCID
- Venue
- Trials
- Published
- 2024-11-14
- Volume
- 25
- Issue
- 1
- Pages
- 767-767
- ISSN
- 1745-6215 (ISSN-L)
- PMC
- PMC11566082
- OpenAlex
- W4404374384
- Cited by
- 3
- References
- 52
- Citations by year
- 2026: 2 · 2025: 1
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Update notices
- correction (2026-06-30)
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Trials (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PUBLISSO (German National Library of Medicine) (submittedVersion, cc-by)
- Online Publication Service of Würzburg University (Würzburg University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Julius-Maximilians-Universität Würzburg
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Health Professions › General Health Professions › Health Policy Implementation Science
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- breast cancer, follow-up care, late effects of cancer treatment, neurotoxicity, cardiotoxicity, health-related quality of life, medication adherence, just-in-time adaptive interventions, digital platforms, multidisciplinary care network
- MeSH terms
- Aftercare, Breast Neoplasms, Feasibility Studies, Female, Germany, Humans, Middle Aged, Pilot Projects, Quality of Life, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial. https://app.cochat.ai/papers/10.1186/s13063-024-08614-8
- The paper
- Schäfer, A., Wendel, J., Franke, I., Bauer, A., Baumeister, H., Bendig, E., Brucker, S. Y., Deutsch, T. M., Garatva, P., Haas, K., Heil, L., Hügen, K., Manger, H., Pryss, R., Rücker, V., Salmen, J., Szczesny, A., Vogel, C., Wallwiener, M., . . . Zorr, A. (2024). The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial. Trials. https://doi.org/10.1186/s13063-024-08614-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.